Literature DB >> 5069902

Myopathy from E-aminocaproic acid: a second case.

J R Bennett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5069902      PMCID: PMC2495239          DOI: 10.1136/pgmj.48.561.440

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  6 in total

Review 1.  AMINOCAPROIC ACID, AN INHIBITOR OF FIBRINOLYSIS.

Authors:  W M SWEENEY
Journal:  Am J Med Sci       Date:  1965-05       Impact factor: 2.378

2.  Absorption of hydrocortisone from the large bowel.

Authors:  P A SAMPSON; B N BROOKE
Journal:  Lancet       Date:  1963-03-30       Impact factor: 79.321

3.  xi-Aminocaproic acid: an inhibitor of plasminogen activation.

Authors:  N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal:  J Biol Chem       Date:  1959-04       Impact factor: 5.157

4.  Rectal hydrocortisone.

Authors:  J D NABARRO; A MOXHAM; G WALKER; J D SLATER
Journal:  Br Med J       Date:  1957-08-03

5.  Extensive muscle necrosis after long-term treatment with aminocaproic acid (EACA) in a case of hereditary periodic edema.

Authors:  K Korsan-Bengtsen; L Ysander; G Blohmé; E Tibblin
Journal:  Acta Med Scand       Date:  1969-04

6.  Epsilon-aminocaproic acid therapy in ulcerative colitis.

Authors:  R H Salter; A E Read
Journal:  Gut       Date:  1970-07       Impact factor: 23.059

  6 in total
  2 in total

Review 1.  Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage.

Authors:  Mark Chwajol; Robert M Starke; Grace H Kim; Stephan A Mayer; E Sander Connolly
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

2.  Epsilon aminocaproic acid (EACA) myopathy.

Authors:  R J Lane; N J McLelland; A M Martin; F L Mastaglia
Journal:  Postgrad Med J       Date:  1979       Impact factor: 2.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.